Edition:
United States

Profile: Inovalon Holdings Inc (INOV.O)

INOV.O on Nasdaq

14.52USD
22 May 2019
Change (% chg)

$0.19 (+1.33%)
Prev Close
$14.33
Open
$14.27
Day's High
$14.60
Day's Low
$14.27
Volume
334,043
Avg. Vol
507,598
52-wk High
$15.57
52-wk Low
$9.19

Inovalon Holdings, Inc., incorporated on September 11, 2014, is a technology company. The Company combines cloud-based data analytics and data-driven intervention platforms to provide services for health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. The Company operates through developing cloud-based data analytics and data-driven intervention platforms segment and provides related services to its clients. The Company's datasets, integration technologies, predictive analytics and subject matter expertise allow the Company to provide platforms. Its analytics platforms identify gaps in care, quality, data integrity and financial performance in its clients' datasets. The Company's data analytics and intervention platforms consist of four primary components: data integration, analytics, intervention platforms and business processing. The Company integrates data into its systems through its extract, transform, load (ETL) tools and processes.

The Company's system manages the process of defining and configuring industry data feeds from its clients and partners, such as electronic health records (EHR), laboratory, pharmacy, patient reported, claims, paper based medical records, biometric and hospital data feeds respectively; manages the data processing workflow, and monitors the ongoing provision and quality of data through the application of data integrity checks. In addition, to being maintained and tagged within client-specific data lakes, data the Company receives in the course of providing its services are statistically de-identified and stored in its MORE2 Registry. The MORE2 Registry includes information about demographics, enrollment, diagnoses, procedures, pharmacy, laboratory results and deep medical record clinical data, and presents a representative mix of commercial, HIX Marketplace, Medicare Advantage and managed Medicaid care plan patients. The Company's data-driven intervention platforms are toolsets and services that enable its clients to take the insights derived from its analytics and implement solutions at the patient and provider level. The Company's business processing toolsets are made up of business intelligence system and data warehousing to provide data insight, reporting and benchmarking to support multiple client business needs, such as government-mandated data filings, financial planning and compliance requirements.

iPort is its data integration and management process toolset. Its Predictive Clinical Insight System (PCIS) identifies the diagnoses and comorbidities that may exist for a patient but which are incompletely or improperly reflected within the clinical profile of the patient as known to the patient's health plan. The PCIS system is designed to evaluate patients for undocumented conditions, worsening conditions and uncoded conditions that are important for the ongoing management of the patient. Its Quality Spectrum Insights Suite (QSI, QSFD and QSCL) toolsets provide a run-time engine tools for the design, development and deployment of a set of healthcare data analytics across the spectrum of clinical and quality outcomes, healthcare utilization, spending patterns, provider and network performance and patient risk profiles. QSI operates on both traditional relational database architectures, as well as on big data architectures within the QSCL and QSI-XL versions of the system. Its Monthly Member Detail Map (MMDM) aggregates analytical outputs of other analytical toolsets to arrive at a gap resolution plan informing intervention strategies to resolve gaps in care, quality and financial performance across populations. Its Data Diagnostics technology provides a suite of patient-specific analyses that can be ordered individually by clinicians on demand with the answer provided within seconds.

The Company's ePASS is an electronic patient assessment solution suite. ePASS is a Web-enabled, point-of-care decision support tool designed to deliver both patient-level insight and guided clinical decision support. Its Site Review Support Application (SRSA) coordinates clinical data collection at facilities across the nation. The Company's Integrated Data Collection Tool (iDCT) facilitates the recordation of clinical information into discrete data elements from a range of clinical data sources. Its Integrated Telephonic Communication Coordinator (iTCC) provides patient engagement, outbound and inbound communications, and provides profiles to make communications. Claims Aggregation, Analysis and Submissions system (CAAS) provides claims data warehousing and processing to support government-mandated data submissions and cost reporting. Its INDICES toolset is an enterprise-level, Web-enabled business intelligence reporting toolset that provides visualization of data and results to authorize client users through dashboards, reports and ad hoc queries.

The Company competes with Oracle, Dell, SAP, SAS, IBM, Accenture, Deloitte Consulting, Optum, McKesson, Verscend Technologies, QuintilesIMS, Change Healthcare, DST Health, The Advisory Board Company, edifecs and Silverlink.

Company Address

Inovalon Holdings Inc

4321 Collington Rd
BOWIE   MD   20716-2259
P: +1301.8094000
F: +1301.8098060

Company Web Links